Intas Pharma gets exclusive rights to commercialize Etanercept biosimilars in more than 150 countries across globe Ruchika Sharma25 Dec 2023 11:30 AM ISTAhmedabad: Intas Pharmaceuticals Ltd., a multinational pharmaceutical company, has announced a strategic exclusive licensing agreement with...
Intas Pharma gets USFDA warning letter due to manufacturing lapses at Ahmedabad plant Ruchika Sharma11 Dec 2023 11:30 AM IST"Repeated failures demonstrate that executive management oversight and control over the manufacture of drugs is inadequate," USFDA said.
Intas Pharma to commercialise Serplulimab in India Ruchika Sharma30 Oct 2023 3:29 PM ISTSerplulimab will be commercialised by Intas in India and by its subsidiary, Accord Healthcare Ltd, in Europe.
Intas Pharma Sanand plant gets USFDA warning letter Ruchika Sharma7 Aug 2023 12:30 PM IST"Our investigators observed plastic bags filled with torn and discarded original CGMP documents in your quality control scrap area under a stairwell,...
Intas Pharma marketing authorization application for proposed biosimilar of Stelara accepted by EMA Ruchika Sharma15 July 2023 11:00 AM ISTDMB-3115 is a proposed biosimilar to Stelara which is a blockbuster drug developed by Janssen Biotech Inc. for plaque psoriasis, psoriatic arthritis,...
Intas Pharma, Syna Therapeutics ink pact for commercialization of LB-0702 in Global Markets Ruchika Sharma6 Nov 2022 2:00 PM ISTAhmedabad: Syna Therapeutics, a joint venture of Reig Jofre and Leanbio, has signed a global rights licensing deal with Intas Pharmaceuticals...
Anti-trust regulator CCI clears Abu Dhabi Investment Authority minority stake acquisition in Intas Pharma Ruchika Sharma11 Oct 2022 11:15 AM ISTNew Delhi: Anti-trust regulator Competition Commission of India (CCI) has cleared Platinum Owl's acquisition of a minority stake in Intas...
Intas Pharma, Comera Life Sciences ink pact for bio-innovative biologic medicines Ruchika Sharma20 April 2022 11:19 AM ISTAhmedabad: Comera Life Sciences, Inc. and Intas Pharmaceuticals Ltd. have announced a research collaboration to develop a new...
Intas Pharma, Axantia collaborate for Ranibizumab in Middle East Ruchika Sharma5 April 2022 12:20 PM ISTIntas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA and the...
Intas pharma gets CDSCO panel nod to manufacture, market schizophrenia drug Clozapine Susmita Roy21 Feb 2022 5:00 PM ISTNew Delhi: Pharmaceutical major Intas Pharmaceuticals has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Intas Pharma unveils antifungal drug SB-100mg Itraconazole Roshni Dhar21 Oct 2021 4:40 PM ISTIn a progressive breakthrough in the Antifungal Therapy domain, Intas Pharmaceuticals has launched the world's first Super Bioavailable...
First: Intas Pharma launches antifungal drug SB-100mg Itraconazole Ruchika Sharma18 Oct 2021 11:45 AM ISTPatients can take Itaspor SB Forte/ Subawin with or without a meal with just water or as directed by the physician.
